{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T20:56:19Z","timestamp":1774126579931,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:00:00Z","timestamp":1697414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:00:00Z","timestamp":1697414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["European J Hybrid Imaging"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hepatic steatosis is the most common chronic hepatic disease. Imaging diagnosis of hepatic steatosis has been evaluated as an alternative to invasive histological diagnosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Study aims<\/jats:title>\n                <jats:p>The study aimed to assess the effect of hepatic steatosis on Flourine-18 fluorodeoxyglucose (18F-FDG) uptakes in cancer patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Patients and Methods<\/jats:title>\n                <jats:p>Blood samples were collected from 50 cancer patients and analyzed to calculate fatty liver index and Hepatic steatosis index (HIS). Hepatic steatosis examined using high-resolution ultrasound and positron emission tomography\u2014computed tomography (PET-CT). Linear attenuation coefficient, standardized-uptake value (SUV) mean (SUV mean), and SUV maximum (SUVmax) were measured. Accordingly, patients were divided equally into non-fatty liver, and fatty liver groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A significant increase in SUVmax and SUV mean was observed in the fatty liver group more than in the non-fatty liver group. HSI significantly increased in the fatty liver group compared to the non-fatty liver group. Liver tissue uptake FDG was significantly correlated with HSI values. SUV max significantly correlated with body mass index (BMI) in the non-fatty group only.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Hepatic changes in cancer patients affect the liver metabolic activity and thus the 18 F-FDG uptake. Therefore, further corrections should be considered when the liver is used as a comparator for PET-CT scans of cancer patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s41824-023-00173-6","type":"journal-article","created":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T23:01:51Z","timestamp":1697410911000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The effect of hepatic steatosis on 18F-FDG uptake in PET-CT examinations of cancer Egyptian patients"],"prefix":"10.1186","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6529-536X","authenticated-orcid":false,"given":"Magdi A.","family":"Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman","family":"El-Abd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Morsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed M.","family":"El Safwany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Z.","family":"El-Sayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,16]]},"reference":[{"issue":"1","key":"173_CR1","doi-asserted-by":"publisher","first-page":"176","DOI":"10.2214\/AJR.10.4679","volume":"196","author":"G Abikhzer","year":"2011","unstructured":"Abikhzer G, Alabed YZ, Azoulay L, Assayag J, Rush C (2011) Altered hepatic metabolic activity in patients with hepatic steatosis on FDG PET\/CT. Am J Roentgenol 196(1):176\u2013180","journal-title":"Am J Roentgenol"},{"key":"173_CR2","doi-asserted-by":"publisher","first-page":"110482","DOI":"10.1016\/j.radphyschem.2022.110482","volume":"201","author":"A Ahmed","year":"2022","unstructured":"Ahmed A, Ali M, Salah H et al (2022) Evaluation of uptake values of FDG: body surface area Vs. body weight correction. Radiat Phys Chem 201:110482. https:\/\/doi.org\/10.1016\/j.radphyschem.2022.110482","journal-title":"Radiat Phys Chem"},{"issue":"10","key":"173_CR3","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.4254\/wjh.v13.i10.1203","volume":"13","author":"S Alam","year":"2021","unstructured":"Alam S, Fahim SM (2021) Transition of an acronym from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease. World J Hepatol 13(10):1203\u20131207","journal-title":"World J Hepatol"},{"issue":"2","key":"173_CR4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ajg.2019.05.004","volume":"20","author":"M Alboraie","year":"2019","unstructured":"Alboraie M, Youssef N, Sherief AF, Afify S, Wifi MN, Omran D, Hafez E, Omar H, Eltabbakh M, Abdellah M, El Badry M (2019) Egyptian liver library: an indexed database for liver disease evidence in Egypt. Arab J Gastroenterol 20(2):109\u2013113","journal-title":"Arab J Gastroenterol"},{"issue":"5","key":"173_CR5","doi-asserted-by":"publisher","first-page":"696","DOI":"10.21037\/hbsn-21-269","volume":"10","author":"J Alharthi","year":"2021","unstructured":"Alharthi J, Eslam M (2021) Metabolic associated fatty liver disease (MAFLD): a milestone in the history of fatty liver disease. Hepatobiliary Surg Nutrit 10(5):696","journal-title":"Hepatobiliary Surg Nutrit"},{"issue":"28","key":"173_CR6","doi-asserted-by":"publisher","first-page":"3510","DOI":"10.3748\/wjg.v16.i28.3510","volume":"16","author":"R Allan","year":"2010","unstructured":"Allan R, Thoirs K, Phillips M (2010) Accuracy of ultrasound to identify chronic liver disease. World J Gastroenterol WJG 16(28):3510","journal-title":"World J Gastroenterol WJG"},{"issue":"4","key":"173_CR7","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/hep.21496","volume":"45","author":"P Angulo","year":"2007","unstructured":"Angulo P, Hui JM, Marchesini G, Bugianesi E, George J, Farrell GC, Enders F, Saksena S, Burt AD, Bida JP, Lindor K (2007) The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 45(4):846\u2013854","journal-title":"Hepatology"},{"issue":"72","key":"173_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.metabol.2017.04.003","volume":"1","author":"S Ballestri","year":"2017","unstructured":"Ballestri S, Nascimbeni F, Baldelli E, Marrazzo A, Romagnoli D, Targher G, Lonardo A (2017) Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic\/ histological parameters in various liver diseases. Metabolism 1(72):57\u201365","journal-title":"Metabolism"},{"issue":"1","key":"173_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C (2006) The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 6(1):1\u20137","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"173_CR10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00330-010-1905-5","volume":"21","author":"AE Bohte","year":"2011","unstructured":"Bohte AE, Van Werven JR, Bipat S, Stoker J (2011) The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis. Eur Radiol 21(1):87\u201397","journal-title":"Eur Radiol"},{"issue":"3","key":"173_CR11","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s11307-009-0258-4","volume":"12","author":"GG Bural","year":"2010","unstructured":"Bural GG, Torigian DA, Burke A, Houseni M, Alkhawaldeh K, Cucchiara A, Basu S, Alavi A (2010) Quantitative assessment of the hepatic metabolic volume product in patients with diffuse hepatic steatosis and normal controls through use of FDG-PET and MR imaging: a novel concept. Mol Imag Biol 12(3):233\u2013239","journal-title":"Mol Imag Biol"},{"issue":"70","key":"173_CR12","first-page":"277","volume":"1","author":"B Canbakan","year":"2007","unstructured":"Canbakan B, Senturk HA, Tahan V, Hatemi I, Balci H, Toptas T, Sonsuz A, Velet M, Aydin S, Dirican A, Ozgulle S (2007) Clinical, biochemical and histological correlations in a group of non-drinker subjects with non-alcoholic fatty liver disease. Acta Gastro-Enterol Belgica 1(70):277\u2013284","journal-title":"Acta Gastro-Enterol Belgica"},{"issue":"5","key":"173_CR13","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","volume":"156","author":"L Castera","year":"2019","unstructured":"Castera L, Friedrich-Rust M, Loomba R (2019) Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease. Gastroenterology 156(5):1264\u20131281","journal-title":"Gastroenterology"},{"issue":"8","key":"173_CR14","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.jcmg.2010.06.004","volume":"3","author":"T Christen","year":"2010","unstructured":"Christen T, Sheikine Y, Rocha VZ, Hurwitz S, Goldfine AB, Di Carli M, Libby P (2010) Increased glucose uptake in visceral versus subcutaneous adipose tissue revealed by PET imaging. JACC Cardiovascular Imaging 3(8):843\u201351","journal-title":"JACC Cardiovascular Imaging"},{"issue":"11","key":"173_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.572490","volume":"18","author":"TS Della","year":"2020","unstructured":"Della TS (2020) Non-alcoholic fatty liver disease as a canonical example of metabolic inflammatory-based liver disease showing a sex-specific prevalence: relevance of estrogen signaling. Front Endocrinol 18(11):572490","journal-title":"Front Endocrinol"},{"issue":"1","key":"173_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-33419-6","volume":"8","author":"R Fan","year":"2018","unstructured":"Fan R, Wang J, Du J (2018) Association between body mass index and fatty liver risk: a dose-response analysis. Sci Rep 8(1):1\u20137","journal-title":"Sci Rep"},{"issue":"6","key":"173_CR17","first-page":"496","volume":"31","author":"JW Fletcher","year":"2010","unstructured":"Fletcher JW, Kinahan PE (2010) PET\/CT standardized uptake values (SUVs) in clinical practice and assessing response to therapy. NIH Public Access 31(6):496\u2013505","journal-title":"NIH Public Access"},{"key":"173_CR18","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.15908","author":"S Giri","year":"2022","unstructured":"Giri S, Agarwal D, Afzalpurkar S (2022) GGT dynamic for advanced fibrosis in NAFLD\u2013novel but not convincing. J Gastroenterol Hepatol. https:\/\/doi.org\/10.1111\/jgh.15908","journal-title":"J Gastroenterol Hepatol."},{"key":"173_CR19","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/623036","author":"AW Glaudemans","year":"2013","unstructured":"Glaudemans AW, de Vries EF, Galli F, Dierckx RA, Slart RH, Signore A (2013) The use of F-FDG-PET\/CT for diagnosis and treatment monitoring of inflammatory and infectious diseases. Clin Develop Immunol. https:\/\/doi.org\/10.1155\/2013\/623036","journal-title":"Clin Develop Immunol"},{"issue":"6","key":"173_CR20","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.4103\/jfmpc.jfmpc_193_18","volume":"7","author":"R Hajong","year":"2018","unstructured":"Hajong R, Dhal MR, Naku N, Kapa B (2018) Incidence of nonalcoholic fatty liver disease in patients undergoing laparoscopic cholecystectomy. J Fam Med Prim Care 7(6):1375","journal-title":"J Fam Med Prim Care"},{"issue":"3","key":"173_CR21","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1002\/hep.24452","volume":"54","author":"R Hernaez","year":"2011","unstructured":"Hernaez R, Lazo M, Bonekamp S, Kamel I, Brancati FL, Guallar E, Clark JM (2011) Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta- analysis. Hepatology 54(3):1082\u20131090","journal-title":"Hepatology"},{"issue":"30","key":"173_CR22","doi-asserted-by":"publisher","first-page":"11066","DOI":"10.12998\/wjcc.v10.i30.11066","volume":"10","author":"N Hu","year":"2022","unstructured":"Hu N, Su SJ, Li JY et al (2022) Hepatic steatosis with mass effect: a case report. World J Clin Cases 10(30):11066\u201311073. https:\/\/doi.org\/10.12998\/wjcc.v10.i30.11066","journal-title":"World J Clin Cases"},{"key":"173_CR23","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20211769","author":"W Jiang","year":"2021","unstructured":"Jiang W, Liu CH, Wu D, Wang YJ, Tang H (2021) Abnormal transaminase and lipid profiles in coexisting diseases in patients with fatty liver: a population study in Sichuan. Biosci Rep. https:\/\/doi.org\/10.1042\/BSR20211769"},{"issue":"10","key":"173_CR24","doi-asserted-by":"publisher","first-page":"5227","DOI":"10.3390\/ijerph18105227","volume":"18","author":"O Juanola","year":"2021","unstructured":"Juanola O, Mart\u00ednez-L\u00f3pez S, Franc\u00e9s R, G\u00f3mez-Hurtado I (2021) Non-alcoholic fatty liver disease: metabolic, genetic, epigenetic and environmental risk factors. Int J Environ Res Public Health 18(10):5227","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"173_CR25","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3350\/cmh.2021.0178","volume":"27","author":"SH Kang","year":"2021","unstructured":"Kang SH, Lee HW, Yoo JJ, Cho Y, Kim SU, Lee TH, Jang BK, Kim SG, Ahn SB, Kim H, Jun DW (2021) KASL clinical practice guidelines: management of nonalcoholic fatty liver disease. Clin Mol Hepatol 27(3):363","journal-title":"Clin Mol Hepatol"},{"issue":"3","key":"173_CR26","doi-asserted-by":"publisher","first-page":"643","DOI":"10.2214\/AJR.13.12147","volume":"203","author":"G Keramida","year":"2014","unstructured":"Keramida G, Potts J, Bush J, Verma S, Dizdarevic S, Peters AM (2014) Accumulation of 18F-FDG in the liver in hepatic steatosis. Am J Roentgenol 203(3):643\u2013648","journal-title":"Am J Roentgenol"},{"issue":"5","key":"173_CR27","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.ejrad.2014.01.027","volume":"83","author":"G Keramida","year":"2014","unstructured":"Keramida G, Potts J, Bush J, Dizdarevic S, Peters AM (2014) Hepatic steatosis is associated with increased hepatic FDG uptake. Eur J Radiol 83(5):751\u2013755","journal-title":"Eur J Radiol"},{"issue":"2","key":"173_CR28","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/cpf.12610","volume":"40","author":"G Keramida","year":"2020","unstructured":"Keramida G, Roldao Pereira L, Kaya G, Peters AM (2020) Hepatic and splenic 18F-FDG blood clearance rates (Ki) in hepatic steatosis and diabetes mellitus. Clin Physiol Funct Imaging 40(2):99\u2013105","journal-title":"Clin Physiol Funct Imaging"},{"issue":"12","key":"173_CR29","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1097\/RLU.0b013e3182335f60","volume":"36","author":"YH Kim","year":"2011","unstructured":"Kim YH, Kim JY, Jang SJ, Chung HW, Jang KS, Paik SS, Song SY, Choi YY (2011) F-18 FDG uptake in focal fatty infiltration of liver mimicking hepatic malignancy on PET\/CT images. Clin Nucl Med 36(12):1146\u20131148","journal-title":"Clin Nucl Med"},{"key":"173_CR30","first-page":"2019","volume":"7","author":"A Kitae","year":"2019","unstructured":"Kitae A, Hashimoto Y, Hamaguchi M, Obora A, Kojima T, Fukui M (2019) The triglyceride and glucose index is a predictor of incident nonalcoholic fatty liver disease: a population- based cohort study. Can J Gastroenterol Hepatol 7:2019","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"10","key":"173_CR31","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.12565","volume":"2","author":"DE Kleiner","year":"2019","unstructured":"Kleiner DE, Brunt EM, Wilson LA, Behling C, Guy C, Contos M, Cummings O, Yeh M, Gill R, Chalasani N, Neuschwander-Tetri BA (2019) Association of histologic disease activity with progression of nonalcoholic fatty liver disease. JAMA Netw Open 2(10):e1912565","journal-title":"JAMA Netw Open"},{"key":"173_CR32","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.2214\/AJR.06.0992","volume":"188","author":"Y Kodama","year":"2007","unstructured":"Kodama Y, Ng C, Wu TT, Ayers G, Curley S, Abdalla E, Vauthey N, Chamsangavej C (2007) Comparison of CT methods for determining the fat content of the liver. Am J Roentgenol 188:1307\u20131312","journal-title":"Am J Roentgenol"},{"issue":"7","key":"173_CR33","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","volume":"42","author":"JH Lee","year":"2010","unstructured":"Lee JH, Kim D, Kim HJ, Lee CH, Yang JI, Kim W, Kim YJ, Yoon JH, Cho SH, Sung MW, Lee HS (2010) Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis 42(7):503\u2013508","journal-title":"Dig Liver Dis"},{"issue":"6","key":"173_CR34","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.clinimag.2011.02.005","volume":"35","author":"CY Lin","year":"2011","unstructured":"Lin CY, Lin WY, Lin CC, Shih CM, Jeng LB, Kao CH (2011) The negative impact of fatty liver on maximum standard uptake value of liver on FDG PET. Clin Imaging 35(6):437\u2013441","journal-title":"Clin Imaging"},{"issue":"7","key":"173_CR35","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1097\/MNM.0000000000000301","volume":"36","author":"G Liu","year":"2015","unstructured":"Liu G, Li Y, Hu P, Cheng D, Shi H (2015) The combined effects of serum lipids, BMI, and fatty liver on 18F-FDG uptake in the liver in a large population from China: an 18F-FDG- PET\/CT study. Nucl Med Commun 36(7):709\u2013716","journal-title":"Nucl Med Commun"},{"issue":"4","key":"173_CR36","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ejro.2017.07.001","volume":"1","author":"GC Lo","year":"2017","unstructured":"Lo GC, Besa C, King MJ, Kang M, Stueck A, Thung S, Wagner M, Smith AD, Taouli B (2017) Feasibility and reproducibility of liver surface nodularity quantification for the assessment of liver cirrhosis using CT and MRI. European J Radiol Open 1(4):95\u2013100","journal-title":"European J Radiol Open"},{"issue":"2","key":"173_CR37","doi-asserted-by":"publisher","first-page":"75","DOI":"10.5603\/NMR.2013.0039","volume":"16","author":"WH Luk","year":"2013","unstructured":"Luk WH, San Au-Yeung AW, Loke TK (2013) Imaging patterns of liver uptakes on PET scan: pearls and pitfalls. Nuclear Med Rev 16(2):75\u201381","journal-title":"Nuclear Med Rev"},{"issue":"3","key":"173_CR38","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.crad.2018.12.009","volume":"74","author":"S McDermott","year":"2019","unstructured":"McDermott S, Kilcoyne A, Wang Y, Scott JA, Halpern EF, Ackman JB (2019) Comparison of the 18F-FDG avidity at PET of benign and malignant pure ground-glass opacities: a paradox? Clin Radiol 74(3):187\u2013195","journal-title":"Clin Radiol"},{"key":"173_CR39","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/145754","author":"M Obika","year":"2012","unstructured":"Obika M, Noguchi H (2012) Diagnosis and evaluation of nonalcoholic fatty liver disease. Exper Diabet Res. https:\/\/doi.org\/10.1155\/2012\/145754","journal-title":"Exper Diabet Res"},{"issue":"11","key":"173_CR40","first-page":"709","volume":"96","author":"RC Oh","year":"2017","unstructured":"Oh RC, Hustead TR, Ali SM, Pantsari MW (2017) Mildly elevated liver transaminase levels: causes and evaluation. Am Fam Physician 96(11):709\u2013715","journal-title":"Am Fam Physician"},{"issue":"1","key":"173_CR41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4274\/eamr.galenos.2018.03779","volume":"35","author":"T \u00d6z\u00fclker","year":"2019","unstructured":"\u00d6z\u00fclker T, \u00d6z\u00fclker F (2019) Assessment of the effect of fat infiltration on hepatic FDG uptake. European Arch Med Res 35(1):27\u201332","journal-title":"European Arch Med Res"},{"issue":"3","key":"173_CR42","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s13139-012-0143-y","volume":"46","author":"K Pak","year":"2012","unstructured":"Pak K, Kim SJ, Kim IJ, Kim K, Kim H, Kim SJ (2012) Hepatic FDG uptake is not associated with hepatic steatosis but with visceral fat volume in cancer screening. Nucl Med Mol Imaging 46(3):176\u2013181","journal-title":"Nucl Med Mol Imaging"},{"issue":"1","key":"173_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43066-020-00043-x","volume":"10","author":"J Paul","year":"2020","unstructured":"Paul J (2020) Recent advances in non-invasive diagnosis and medical management of non-alcoholic fatty liver disease in adult. Egyptian Liver J 10(1):1\u20138","journal-title":"Egyptian Liver J"},{"issue":"9","key":"173_CR44","doi-asserted-by":"publisher","first-page":"4277","DOI":"10.7150\/thno.40249","volume":"10","author":"AM Pirmoazen","year":"2020","unstructured":"Pirmoazen AM, Khurana A, El Kaffas A, Kamaya A (2020) Quantitative ultrasound approaches for diagnosis and monitoring hepatic steatosis in nonalcoholic fatty liver disease. Theranostics 10(9):4277","journal-title":"Theranostics"},{"issue":"122","key":"173_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2019.108743","volume":"1","author":"L Rozenblum","year":"2020","unstructured":"Rozenblum L, Mokrane FZ, Yeh R, Sinigaglia M, Besson FL, Seban RD, Zadro C, Dierickx L, Chougnet CN, Partouche E, Revel-Mouroz P (2020) Imaging-guided precision medicine in non-resectable gastro-entero-pancreatic neuroendocrine tumors: a step-by-step approach. Eur J Radiol 1(122):108743","journal-title":"Eur J Radiol"},{"issue":"1","key":"173_CR46","first-page":"75","volume":"21","author":"AI Salama","year":"2020","unstructured":"Salama AI, Mohamed Houseni M, Elsheshiny AA (2020) Effect of chemotherapy on liver metabolism as measured by PET\/CT scan. Egyptian J Biomed Eng Biophys 21(1):75\u201385","journal-title":"Egyptian J Biomed Eng Biophys"},{"issue":"6","key":"173_CR47","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s00259-017-3914-y","volume":"45","author":"T Salomon","year":"2018","unstructured":"Salomon T, Nganoa C, Gac AC, Fruchart C, Damaj G, Aide N, Lasnon C (2018) Assessment of alteration in liver 18F\u2013FDG uptake due to steatosis in lymphoma patients and its impact on the Deauville score. Eur J Nucl Med Mol Imaging 45(6):941\u2013950","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"173_CR48","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/hep.24376","volume":"54","author":"AJ Sanyal","year":"2011","unstructured":"Sanyal AJ, Brunt EM, Kleiner DE, Kowdley KV, Chalasani N, Lavine JE, Ratziu V, McCullough A (2011) Endpoints and clinical trial design for nonalcoholic steatohepatitis. Hepatology 54:344\u2013353","journal-title":"Hepatology"},{"issue":"5","key":"173_CR49","doi-asserted-by":"publisher","first-page":"597","DOI":"10.4103\/2230-8210.163172","volume":"19","author":"D Sanyal","year":"2015","unstructured":"Sanyal D, Mukherjee P, Raychaudhuri M, Ghosh S, Mukherjee S, Chowdhury S (2015) Profile of liver enzymes in non-alcoholic fatty liver disease in patients with impaired glucose tolerance and newly detected untreated type 2 diabetes. Indian J Endocrinol Metab 19(5):597\u2013601","journal-title":"Indian J Endocrinol Metab"},{"issue":"5","key":"173_CR50","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1097\/MNM.0000000000001000","volume":"40","author":"SM Seraj","year":"2019","unstructured":"Seraj SM, Al-Zaghal A, Zadeh MZ, Jahangiri P, Pournazari K, Raynor WY, Werner TJ, H\u00f8ilund-Carlsen PF, Alavi A, Hunt SJ (2019) Dynamics of fluorine-18-fluorodeoxyglucose uptake in the liver and its correlation with hepatic fat content and BMI. Nucl Med Commun 40(5):545\u2013551","journal-title":"Nucl Med Commun"},{"issue":"1","key":"173_CR51","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/MEG.0000000000001279","volume":"31","author":"S Softic","year":"2019","unstructured":"Softic S, Kahn RC (2019) Fatty liver disease: is it nonalcoholic fatty liver disease or obesity-associated fatty liver disease? Eur J Gastroenterol Hepatol 31(1):143","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"173_CR52","first-page":"131","volume":"50","author":"KD Stumpe","year":"2006","unstructured":"Stumpe KD, Strobel K (2006) ^ sup 18^ F FDG-PET imaging in musculoskeletal infection. Q J Nucl Med Mol Imaging 50(2):131","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"11","key":"173_CR53","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s00535-021-01796-x","volume":"56","author":"K Tokushige","year":"2021","unstructured":"Tokushige K, Ikejima K, Ono M, Eguchi Y, Kamada Y, Itoh Y, Akuta N, Yoneda M, Iwasa M, Yoneda M, Otsuka M (2021) Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis 2020. J Gastroenterol 56(11):951\u2013963","journal-title":"J Gastroenterol"},{"issue":"44","key":"173_CR54","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.medengphy.2017.02.014","volume":"1","author":"X Zhang","year":"2017","unstructured":"Zhang X, Gao X, Zhang P, Guo Y, Lin H, Diao X, Liu Y, Dong C, Hu Y, Chen S, Chen X (2017) Dynamic mechanical analysis to assess viscoelasticity of liver tissue in a rat model of nonalcoholic fatty liver disease. Med Eng Phys 1(44):79\u201386","journal-title":"Med Eng Phys"}],"container-title":["European Journal of Hybrid Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41824-023-00173-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41824-023-00173-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41824-023-00173-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T08:01:24Z","timestamp":1700380884000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhi.springeropen.com\/articles\/10.1186\/s41824-023-00173-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,16]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["173"],"URL":"https:\/\/doi.org\/10.1186\/s41824-023-00173-6","relation":{"references":[{"id-type":"uri","id":"","asserted-by":"subject"}]},"ISSN":["2510-3636"],"issn-type":[{"value":"2510-3636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,16]]},"assertion":[{"value":"7 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the Medical Research Institute, Alexandria University, Egypt.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Subjects were recruited according to the rules of Ayadi Al-Mostakbal ethical committee for conduction of medical research on human subjects and informed consents were obtained from each patient included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"No Competing interests between authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19"}}